RT Book, Section
A1 Lee Tran, Catherine
A1 Tran, Mark M.
A1 Wang, Timothy S.
A2 Avram, Marc R.
A2 Avram, Mathew M.
A2 Ratner, Désirée
SR Print(0)
ID 1175094556
T1 Management of Advanced Nonmelanoma Skin Cancer
T2 Procedural Dermatology
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071795067
LK dermatology.mhmedical.com/content.aspx?aid=1175094556
RD 2024/04/19
AB Skin  cancers  are  divided  into  two  main  groups:  malignant  melanoma  (MM)  and  nonmelanoma  skin  cancer  (NMSC).  The  term  “NMSC”  encompasses  a  wide  variety  of  skin  cancers  including  basal  cell  carcinomas  (BCC),  cutaneous  squamous  cell  carcinomas  (cSCC),  dermatofibrosarcoma  protuberans  (DFSP),  cutaneous  lymphomas,  adnexal  tumors,  and  Merkel  cell  carcinoma  (MCC),  and  only  excludes  malignancies  involving  melanocytes.  BCC  and  cSCC  comprise  the  vast  majority  of  NMSC  tumors  (estimated  between  75%  and  80%  and  20%  and  25%,  respectively)1,2  and  their  incidence  is  approximately  18  to  20  times  higher  than  that  of  MM.3  This  chapter  will  focus  on  the  management  of  advanced  BCC,  cSCC,  DFSP,  and  MCC.